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Chromatin functions to package and regulate genomic information within 
eukaryotic cells and can be present in two distinct states, heterochromatin and 
euchromatin. Chromatin conformation is dictated by a vast array of epigenetic post-
translational modifications (PTMs). One particularly complex PTM is histone tail 
methylation, catalyzed by histone methyltransferases (HMTs), wherein a single amino 
acid residue is mono- (me1), di- (me2), or tri- (me3) methylated; each level of methylation 
contributing to different chromatin states. Histone 3 lysine 9 trimethylation (H3K9me3) is 
a hallmark of heterochromatin formation and is one of the most abundant and stable 
modifications characterized. While the effects of HMTs are known, the individual 
contribution of each HMT remains unidentified. HMTs Suv39h1, SETDB1, and Suv39h2 
all lead to H3K9me2 and H3K9me3, but their discrete roles in the establishment of these 
PTMs remain unclear. Here we laid the groundwork to test and identify the role of 
Suv39h2, by generating a Suv39h2 knockout (KO) mouse ES cell line using CRISPR-
Cas9. While the DNA sequence of the Suv39h2 KO cells showed successful In/Del 
mutations, western blots indicated retained protein content. In the future, a dCas9-
mediated Suv39h2 gene knockdown will be used to generate another mouse ES cell line, 








Chromatin functions to package and regulate the genomic information within 
eukaryotic cells. Nuclear DNA is wrapped around the nucleosome, a complex built by an 
octamer of four core histones (H3, H4, H2A, H2B). The core histone proteins possess N-
terminal ‘tails’, which extend from the nucleosome core and are the target of post-
translational modifications (PTMs) that contribute to gene expression regulation. 
Chromatin can be present in two distinct states, heterochromatin and euchromatin. In 
heterochromatin, nucleosomes are highly condensed, making DNA hard to reach by 
transcriptional machinery; while in euchromatin nucleosomes are relatively open for 
transcription and genes are expressed to a much greater degree. Heterochromatin can 
be constitutive, in regions like telomeres and centromeres, or facultative, in regions that 
vary between differentiated cell types and help regulate and maintain differentiation. 
Constitutive heterochromatin regions are maintained in that state near permanently 
across lineages, in part due to the risk they pose to genome integrity. Facultative 
heterochromatin is compacted dynamically, in many cases as cells differentiate and cell 
lineage-specific genes are no longer needed [7].  
A vast array of epigenetic modifications affect chromatin conformation, including DNA 
methylation and histone PTMs. Common PTMs include acetylation, methylation, 
ubiquitylation, and phosphorylation. Many characterized PTMs contribute to either 
heterochromatin or euchromatin formation, but also affect DNA repair, replication, and 
condensation [2]. PTMs in varying core histone and tail locations have disparate effects, 
and methylation is particularly complex in that a single amino acid residue can be mono- 
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(me1), di- (me2), or tri- (me3) methylated, with each level of methylation bringing about 
different chromatin states and thus differentially affecting gene regulation [2].  
Some PTMs such as histone 3 (H3), lysine 4 and lysine 36 trimethylation (H3K4me3, 
H3K36me3) are associated with euchromatin, while other PTMs such as H3K9me3 and 
H3K27me3 are associated with heterochromatin. H3K9me3 in particular is a hallmark of 
heterochromatin formation and is one of the most abundant and stable PTMs 
characterized [1]. Conversely, H3K9 mono and dimethylation are associated with 
euchromatin formation. Methylation levels in H3K9 are inherited across generations and 
are linked with DNA methylation maintenance at pericentric repeats, and are thus partially 
responsible for maintaining differentiation states [10]. As cells differentiate from 
embryonic stem cells down their developmental line, they repress the expression of non-
type specific genes. H3K9me3 is one of the stable mechanisms through which this 
repression is achieved [8]. 
Methylation is catalyzed by histone methyltransferases (HMTs) with conserved SET-
domains, five of which are H3K9-specific. SETDB1, Suv39h1, and Suv39h2 catalyze 
H3K9m2 and H3K9m3, while GLP and G9a catalyze H3K9m1 and H3K9m2 [3]. 
Heterochromatin protein 1 (HP1) serves as a platform for the recruitment of factors to 
further mediate chromatin condensation. HP1 binds to trimethylated H3K9, self-
oligomerizes and recruits histone modifiers for repression, including Suv39h1/h2 and 
SETDB1. HP1 serves an important role in maintaining pericentric heterochromatin along 
with HMTs, especially Suv39h1/h2. Mammals have three isoforms of HP1 (α, β, γ), which 
possess a chromo-domain (CD) that binds to trimethylated H3K9 and a chromoshadow 
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domain (CSD) that mediates dimerization with the same HP1 isoform. The CSD interacts 
with HMTs and other factors to indirectly mediate H3K9me3 translation [9].  
The most studied H3K9-specific HMT is Suv39h1/h2, which localizes to and 
predominantly regulates pericentric heterochromatin formation and maintenance. 
Suv39h1/h2-HP1 activity is also related to proper DNA methylation in pericentric satellite 
repeats, which is crucial for heterochromatin stability and genome integrity across 
generations [3]. DNA methyltransferase activity is dependent on H3K9me3 machinery for 
pericentric satellite methylation [10]. 
While the overall effects of H3K9 HMTs are known, the individual contribution of each 
HMT remains unidentified. To investigate the individual contribution of Suv39h2 towards 
H3K9me3, the gene was knocked out using the CRISPR-Cas9 system to create a 
Suv39h2-null mouse embryonic stem (ES) cell line. We planned to use the Cia:Oct4 
system, which selectively recruits HP1α to induce H3K9me3-dependent gene silencing 
at the Oct4 gene locus, to compare the heterochromatin formation rates of the Suv39h2 
KO and WT cell lines. Suv39h2 protein presence in western blot analyses and parallel 
issues with a SETDB1 KO cell line led us to change our approach to a dCas9-mediated 
gene knock-down (KD). The generation of the KD Suv39h2 cell line is currently in 
progress. 
  
Materials and Methods 
CRISPR-Cas9 KO 
Desirable mutation sites for the Suv39h2 gene were searched for using the UCSC 
genome browser and NCBI Blast. Sites near the beginning of the transcription site were 
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given priority and three guides were chosen (Table 1 and Appendix). Oligonucleotides for 
these sequences were ordered from Eton Bioscience.  
The oligonucleotides were annealed with 15 µL each of the forward and reverse 
oligonucleotides to 45 µL of annealing buffer (Sigma Aldrich: 10mM Tris pH 8, 50mM 
NaCl, 1mM EDTA) and incubating mixture in the thermocycler at 92 ºC for 2 minutes, then 
72 ºC for 2 minutes, 55 ºC for 2 minutes, and 37 ºC for 2 minutes. 1 µL of the resulting 
oligonucleotide duplex was ligated into a 50 ng plasmid vector (pSpCas9(BB)-2A-Puro 
(PX459) V2.0) with puromycin resistance using the restriction enzyme BBSI-hf (New 
England Biosciences), along with 2 µL of 10X T4 ligation buffer, 1 µL T4 ligase, and 14 
µL of molecular grade water. This ligation mixture was incubated overnight at 16 ºC. 
The resulting plasmid was transformed into E. coli cells (OneShot, Invitrogen). The 
OneShot cells were thawed on ice for 30 minutes, 5 µL of the prepared plasmid were 
added and the mixture was incubated in ice for 30 minutes. The mixture was heat-
shocked at 42 ºC for 45 seconds and placed in ice for 2 minutes. 50 µL of S.O.C media 
(Invitrogen) was added to the sample and the vial was placed horizontally in an incubator 
shaker at 37 ºC and 225 rpm for 45 minutes. The mixture was spread on a pre-warmed 
agar plate and incubated overnight at 37ºC in an inverted position. Transformed E. coli 
colonies were individually picked using a p100 µL pipette tip and deposited into 5 mL 
glass vials with 4 mL of Lysogeny Broth (LB) and shaken overnight at 37 ºC and 225 rpm. 
Plasmid DNA was isolated from the grown colonies using a Plasmid Miniprep kit (Zymo 
Research) and sent for sequencing (Eton Bioscience). 
 
PCR mutation screen 
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To quickly identify potential in/del mutations, PCR was used to screen through 
hundreds of isolated colonies’ DNA. Forward and Reverse primers were designed 300-
500 bp up or downstream of the CRISPR target site. A 20mer of the CRISPR target site 
served as a middle primer. PCR reactions with Forward-Reverse and Middle-Reverse 
combinations were set up for each colony’s DNA. PCR reactions were run in a 10% 
agarose gel for 40 minutes at 160 V. Colonies with missing bands from the Middle-
Reverse and Forward-Reverse primer combinations were selected DNA sequencing for 
mutational confirmation.  
Transfection 
After a correct plasmid was identified, the plasmids were transfected into mouse 
embryonic stem (ES) cells. For the transfection, an Amaxa 4D nucleofector was used. 
For each nucleofector cuvette, 2 million ES cells were used along with 5 µg of plasmid 
DNA. The cells used for transfection were PBS washed, treated with 0.25% trypsin 
(Corning) for 8 minutes, quenched with 10 mL of ES media [500 mL DMEM (Corning), 6 
mL 100X MEM (Gibco), 6 mL HEPES (Corning), 6 mL Pen/Strep (Corning), 0.6 mL beta-
mercaptoethanol (Gibco), 1.2 mL LIF (Leukemia Inhibitory Factor)], and centrifuged at 
125 xg for 10 minutes. The pellet was resuspended in 18 µL of nucleofector solution 
supplement and 82 µL of nucleofector solution, and 5 µg of plasmid DNA were added. 
The CY140 program for mouse ES cells was used for transfection. After transfection, cells 
were resuspended in 500 µL of ES media and plated in gelatin-coated 6-well plates. 
Surviving colonies were 1.5 µL of puromycin per mL of ES media. 
Colony picking 
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Selected colonies were picked with a p200 pipette and a microscope inside the 
hood. Individual colonies were transferred into wells in a 96-well plate with 30 µL of trypsin 
per well for 10 minutes, quenched with ES media, and transferred to a previously gelatin-
coated 24 well-plate. These colonies were grown and split into two groups; cells for DNA 
isolation and cells to freeze.  
Western Blotting 
Cells were PBS washed and separated using 0.05% trypsin-EDTA, incubating for 
eight minutes at 37 ºC.  Trypsin was quenched with ES media and spun at 1000 rpm for 
five minutes. The pellet was resuspended in 1 ml of PBS and spun at 1500 rpm for five 
minutes. Cells were lysed with 1.5 ml of M-PER lysis buffer, mixed with the pellet via 
pipetting. 3 ul each of benzoanase and protease inhibitor cocktail were added to the tube, 
vortexing to mix, and incubated in a 37 ºC water bath for 10 minutes. Samples were 
inverted at room temperature for 20 minutes and spun at 1500 rpm for five minutes. 
Absorbance for the Bradford assay was measured at 595 nm using SoftMax Pro 
Software. 
From each sample, 7.5 ul (10-20 ng) of protein was mixed with 7.5 ul of 2X Laemmli 
SDS-loading dye, adding appropriate amounts of BME. Samples were boiled for three 
minutes at 95 ºC and centrifuged at 12000 rpm for 2 minutes, adding 15 ul of each sample 
were loaded per well, and SDS gel was run at 200 V for 40 minutes. 
To transfer samples, the PVDF transfer membrane was pre-soaked for 1 min in 
MeOH, then moved to soak in the transfer buffer. The transfer cassette was assembled 
between two filter papers and placed in the cassette with sponges and filled with the 
transfer buffer. The transfer was run at 100 V for an hour. The PVDF membrane was 
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moved into a blocking buffer and rocked in a -20 ºC cold room for one hour at speed 4. 
The blocking buffer was removed and the primary antibody was added (1:1000 in PBST) 
to each membrane and rocked in the cold room overnight. The primary antibody was 
removed and the membrane was washed with PBS. Secondary antibodies (3.3 ul in 40ml 
PBS) were added and the membrane was rocked in the cold room at slow speed for one 
hour. The membrane was PBS washed and blots were imaged with LiCor. 
Table 1: gRNA Primer sequence 
Gene name Primer sequence (5’-> 3’) 
Suv39h2 SY05401F- CCGTCAGGGTCTCCGCGCGG 
 
Table 2: Antibody information 
Antibody Western blot Source (Catalog number) Dilution 
Actin A Abcam (ab8226) 1:1000 
B 
Suv39h2 A ABclonal-Rabbit (A5855) 1:1000 

















Expected Suv39h2 band 
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Nonsense mutation (TGA), 
Colony #14 
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Figure 1: Generation of Suv39h2 genetic KO cell line 
A. Mutation site (red line) chosen within Exon 1 of the Suv39h2 gene, ~bp 150. B. PCR-
amplified DNA gel, SY05401 colonies run with Middle and Reverse Suv39h2-specific 
primers. C. DNA mutation sequence for SY05401F mutant. D-F. The amino acid 










A. Western blot confirmation of Suv39h2 knockout in the KO cell lines indicating protein 
retention. B. Western blot confirmation of Suv39h2 knockout in the KO cell lines 






Figure 3: Cia:Oct4 repression profile of Suv39h2 genetic KO cells. 
A. Total Cia:Oct4 repression profiles of WT and Suv39h2 genetic KO cells. B. Selected 






Suv39h2 KO cell line generation 
To determine the individual role of Suv39h2 in the trimethylation of H3K9, a 
Suv39h2 knock-out (KO) mouse ES cell line was generated using the CRISPR-Cas9 
system. A suitable target location within exon 1 of the Suv39h2 gene was identified and 
scored using NCBI Blast (Figure 1A). Transfected colonies were pre-screened by PCR. 
SY05401 colonies #8, #11, and #14 lacked a band at the expected sites, suggesting a 
KO had been achieved (Figure 1B). DNA sequencing confirmed the screening results, 
with colony #8 presenting two mutational variants of eight and thirty base pair deletions 
each (Figure 1C). Amino acid sequencing of the mutations in both colony #8 and colony 
#14 indicated nonsense mutations had been generated (Figure 1E, 1F).  
Unsuccessful Suv39h2 protein KO confirmation 
To confirm the absence of Suv39h2 protein, a Western blot was performed in the 
newly generated Suv39h2 KO lines. Initial Western blots showed comparable protein 
expression in the Suv39h2 KO cells and WT Suv39h2 cells using a rabbit-specific 
antibody, contrary to expectations (Figure 2A). Subsequent Western blots showed highly 
non-specific binding of the Suv39h2 antibody, not providing any additional information 
(Figure 2B). Retention was unexpected given the confirmed genetic KO, likely explained 
by plasticity rescue [11]. 
 
 
Heterochromatin repression profile of Suv39h2 genetic KO cell line 
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 Using the Cia:Oct4 system, which recruits HP1α and induces H3K9me3-
dependent heterochromatin formation at the Oct4 gene locus upon rapamycin addition, 
one copy of Oct4 is replaced with eGFP. The silencing of eGFP is an indication of 
heterochromatin formation. The heterochromatin formation rates of the WT and Suv39h2 
genetic KO cells were compared utilizing flow cytometry. The Suv39h2 genetic KO cells 
presented a higher GFP luminescence and GFP-positive cell count at every time point 
after rapamycin addition, denoting a reduced heterochromatin formation rate (Figure 3A). 
Selected data of days 0, 2, and 3 more clearly shows the difference at these time points. 
Notably, the GFP luminescence distribution of the Suv39h2 genetic KO cells on day 3 
closely mimics that of the WT cells on day 2 (Figure 3B).  
Discussion and conclusions 
The guide sequences selected for the mutation locus clustered around the 
beginning of the gene to maximize the probability of downstream nonsense mutations. 
The successful mutation loci were around 150 base pairs downstream of the transcription 
start site, within the gene’s first exon (Figure 1A). Several transfected cell colonies 
exhibited insertion/deletion (In/Del) mutations created using a CRISPR-Cas9 complex. Of 
the 48 SY05401 colonies picked and screened for mutations with PCR using the middle 
and reverse primers, the ones with potential mutations were then screened for false 
positives. Colonies #8, #11, and #14 appear to lack a second band, indicating a mutation 
was likely present (Figure 1B). DNA from these colonies was sequenced, and in/del 
mutations were confirmed. SY05401 colony 8 possessed two variant mutations, one an 
eight base pair and the other a thirty base pair deletion (Figure 1C). This variation is 
consistent with mouse diploidy and suggested a double KO had been achieved. The 
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amino acid sequences for the mutation phenotypes of colonies #8 and #14 indicate 
nonsense mutations occurred in both (Figure 1D-F). Nonsense mutations typically lead 
to non-functional protein products by truncating the protein before translation is complete, 
making a cell line with this mutation type an effective model in which to study the effect 
of a Suv39h2 KO. 
 With the genetic Suv39h2 KO confirmed, western blot analyses were performed to 
verify the cell lines lacked Suv39h2 protein content. The first blot showed bands of similar 
intensity for the WT and KO Suv39h2 cell protein content (Figure 2A), while the second 
blot showed highly unspecific binding across all lanes (Figure 2B). We hypothesize the 
apparent protein retention is due to exon skipping of the edited exon, though the 
functionality of the retained protein remains unexplored [11]. Retention might also be 
caused by translation reinitiation at a later exon.  
Given the confirmed success of the Suv39h2 genetic KO and that the extent of the 
functionality of the retained protein was in doubt, we decided to investigate the effect the 
Suv39h2 genetic KO might have on heterochromatin formation rate. The Suv39h2 genetic 
KO cells showed consistently higher GFP luminescence and GFP-positive cell counts 
using the Cia:Oct4 system and flow cytometry, indicating a reduced heterochromatin 
formation rate (Figure 3A-B). While these data match our expectations of a partial 
reduction in heterochromatin formation rate, inferences about the true importance and 
role of Suv39h2 in heterochromatin formation via H3K9me3 are unfeasible without a clear 
understanding of the retained protein structure and functionality. We expect at least a 
partial loss of function to the Suv39h2 protein in the genetic KO cells, but this expectation 
remains untested.  
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Considering the difficulties facing this project, and further difficulties with a parallel 
project focused on the generation of a SETDB1 KO mouse ES cell line, we decided to 
change our approach to a dCas9-mediated Suv39h2 knockdown (KD). The KD procedure 
should improve the viability of the transfected cells for both SETDB1 and Suv39h2, which 
can both be lethal with double KOs [7], and the end goal of determining the individual 
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2. Full heterochromatin formation profile flow cytometry data for WT and 
genetic KO Suv39h2 mouse ES cells, time course following rapamycin 












4. PCR pre-sequencing screening scheme, first using forward and reverse, 
followed by the middle and reverse primers. 
 
